Sipuleucel-T for the Treatment of Advanced Prostate CancerFROHLICH, Mark W.Seminars in oncology. 2012, Vol 39, Num 3, pp 245-252, issn 0093-7754, 8 p.Article

Vaccines for Melanoma and Renal Cell CarcinomaKAUFMAN, Howard L.Seminars in oncology. 2012, Vol 39, Num 3, pp 263-275, issn 0093-7754, 13 p.Article

Harnessing the unique local immunostimulatory properties of modified vaccinia Ankara (MVA) virus to generate superior tumor-specific immune responses and antitumor activity in a diversified prime and boost vaccine regimenHODGE, James W; HIGGINS, Jack; SCHLOM, Jeffrey et al.Vaccine. 2009, Vol 27, Num 33, pp 4475-4482, issn 0264-410X, 8 p.Article

Intratumoral vaccination and diversified subcutaneous/intratumoral vaccination with recombinant poxviruses encoding a tumor antigen and multiple costimulatory moleculesKUDO-SAITO, Chie; SCHLOM, Jeffrey; HODGE, James W et al.Clinical cancer research. 2004, Vol 10, Num 3, pp 1090-1099, issn 1078-0432, 10 p.Article

Vector-based vaccine/cytokine combination therapy to enhance induction of immune responses to a self-antigen and antitumor activityAARTS, Wilhelmina M; SCHLOM, Jeffrey; HODGE, James W et al.Cancer research (Baltimore). 2002, Vol 62, Num 20, pp 5770-5777, issn 0008-5472, 8 p.Article

Enhanced activation of rhesus T cells by vectors encoding a triad of costimulatory molecules (B7-1, ICAM-1, LFA-3)SHANKAR, Pragyna; SCHLOM, Jeffrey; HODGE, James W et al.Vaccine. 2001, Vol 20, Num 5-6, pp 744-755, issn 0264-410XArticle

Consequence of dose scheduling of sunitinib on host immune response elements and vaccine combination therapyFARSACI, Benedetto; HIGGINS, Jack P; HODGE, James W et al.International journal of cancer (Print). 2012, Vol 130, Num 8, pp 1948-1959, issn 0020-7136, 12 p.Article

Combination of Docetaxel and Recombinant Vaccine Enhances T-Cell Responses and Antitumor Activity : Effects of Docetaxel on Immune EnhancementGARNETT, Charlie T; SCHLOM, Jeffrey; HODGE, James W et al.Clinical cancer research. 2008, Vol 14, Num 11, pp 3536-3544, issn 1078-0432, 9 p.Article

The Tipping Point for Combination Therapy: Cancer Vaccines With Radiation, Chemotherapy, or Targeted Small Molecule InhibitorsHODGE, James W; ARDIANI, Andressa; FARSACI, Benedetto et al.Seminars in oncology. 2012, Vol 39, Num 3, pp 323-339, issn 0093-7754, 17 p.Article

Cancer vaccines targeting carcinoembryonic antigen: state-of-the-art and future promiseGAMEIRO, Sofia R; JAMMEH, Momodou L; HODGE, James W et al.Expert review of vaccines. 2013, Vol 12, Num 6, pp 617-629, issn 1476-0584, 13 p.Article

Immune Impact Induced by PROSTVAC (PSA-TRICOM), a Therapeutic Vaccine for Prostate CancerGULLEY, James L; MADAN, Ravi A; HEERY, Christopher R et al.Cancer immunology research (Print). 2014, Vol 2, Num 2, pp 133-141, issn 2326-6066, 9 p.Article

Novel Recombinant Alphaviral and Adenoviral Vectors for Cancer ImmunotherapyOSADA, Takuya; MORSE, Michael A; HOBEIKA, Amy et al.Seminars in oncology. 2012, Vol 39, Num 3, pp 305-310, issn 0093-7754, 6 p.Article

Strategies to Use Immune Modulators in Therapeutic Vaccines Against CancerBERZOFSKY, Jay A; TERABE, Masaki; WOOD, Lauren V et al.Seminars in oncology. 2012, Vol 39, Num 3, pp 348-357, issn 0093-7754, 10 p.Article

Exploitation of differential homeostatic proliferation of T-cell subsets following chemotherapy to enhance the efficacy of vaccine-mediated antitumor responsesGAMEIRO, Sofia R; CABALLERO, Jorge A; HIGGINS, Jack P et al.Cancer immunology and immunotherapy. 2011, Vol 60, Num 9, pp 1227-1242, issn 0340-7004, 16 p.Article

TRICOM vector based cancer vaccinesGARNETT, Charlie T; GREINER, John W; TSANG, Kwong-Yok et al.Current pharmaceutical design. 2006, Vol 12, Num 3, pp 351-361, issn 1381-6128, 11 p.Article

Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancerGULLEY, James L; ARLEN, Philip M; CAMPHAUSEN, Kevin et al.Clinical cancer research. 2005, Vol 11, Num 9, pp 3353-3362, issn 1078-0432, 10 p.Article

A pan inhibitor of DASH family enzymes induces immunogenic modulation and sensitizes murine and human carcinoma cells to antigen-specific cytotoxic T lymphocyte killing: implications for combination therapy with cancer vaccinesDONAHUE, Renee N; DUNCAN, Brynn B; TSANG, Kwong-Yok et al.Vaccine. 2014, Vol 32, Num 26, pp 3223-3231, issn 0264-410X, 9 p.Article

Lymphoma Vaccine Therapy: Next Steps After a Positive, Controlled Phase III Clinical TrialTHOMAS, Sheeba K; KWAK, Larry W.Seminars in oncology. 2012, Vol 39, Num 3, pp 253-262, issn 0093-7754, 10 p.Article

Use of radiolabeled monoclonal antibody to enhance vaccine-mediated antitumor effectsCHAKRABORTY, Mala; GELBARD, Alexander; CARRASQUILLO, Jorge A et al.Cancer immunology and immunotherapy. 2008, Vol 57, Num 8, pp 1173-1183, issn 0340-7004, 11 p.Article

Combination chemotherapy and radiation of human squamous cell carcinoma of the head and neck augments CTL-mediated lysisGELBARD, Alexander; GARNETT, Charlie T; ABRAMS, Scott I et al.Clinical cancer research. 2006, Vol 12, Num 6, pp 1897-1905, issn 1078-0432, 9 p.Article

Phase I study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinia-CEA(6D)-TRICOM, with and without granulocyte-macrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcinomasMARSHALL, John L; GULLEY, James L; FOX, Evelyn et al.Journal of clinical oncology. 2005, Vol 23, Num 4, pp 720-731, issn 0732-183X, 12 p.Article

Vector-driven hyperexpression of a triad of costimulatory molecules confers enhanced T-cell stimulatory capacity to DC precursorsRAD, Ariel N; SCHLOM, Jeffrey; HODGE, James W et al.Critical reviews in oncology/hematology. 2001, Vol 39, Num 1-2, pp 43-57, issn 1040-8428Conference Paper

Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell deathHODGE, James W; GARNETT, Charlie T; FARSACI, Benedetto et al.International journal of cancer (Print). 2013, Vol 133, Num 3, pp 624-636, issn 0020-7136, 13 p.Article

Combination therapy of an orthotopic renal cell carcinoma model using intratumoral vector-mediated costimulation and systemic lnterleukin-2KUDO-SAITO, Chie; WANSLEY, Elizabeth K; GRUYS, M. Eilene et al.Clinical cancer research. 2007, Vol 13, Num 6, pp 1936-1946, issn 1078-0432, 11 p.Article

Page / 2